REFERENCES
- Kucers A, Crowe SM, Grayson ML (Eds). The Use of An-tibiotics (5th ed.). Oxford: Butterworth-Heinemann; 1997.
- Sensakovic JW, Smith LG. Oral antibiotic treatment of in-fectious diseases. Med Clin North Am 2001; 85: 115–123.
- Cunha BA. Oral antibiotic therapy of serious systemic infections. Med Clin North Am. 2006; 90: 1197–1222.
- Cunha BA, Ristuccia AM: Editors: Antimicrobial Therapy. Raven Press, New York, 1984.
- Cunha BA (Ed.). Antibiotic Essentials (8th ed.). Jones & Bartlett, Sudbury, MA, 2009.
- Cunha BA. Factors in antibiotic selection for hospital for-mularies (Part I). Hospital Formulary 1998; 33: 558–572.
- Waagsbo B, Sundoy A, Paulsen EQ. Reduction of unnecessary IV antibiotic days using general criteria. Scand J Infect Dis. 2008; 40: 468–473.
- Pulcini C, Couadau T, Bernard, et al. Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis. 2008; 27: 1227–1232.
- Cunha BA. Intravenous line infections. Crit Care Clin 1998;8;339–346.
- Raad I, Bodey GP. Infectious complications of indwelling long-term central venous catheters. Infect Dis. 1992; 15: 197–210.
- Cunha BA. (Ed.) Central Intravenous Line Infections in Critical Care. In: Infectious Diseases in Critical Care Medicine (3'3 ed.). Informa, New York, 2009.
- Antoniskis A, Anderson BC, Van Volkinburg EJ, et al. Feasibility of outpatient self-administration of parenteral antibi-otics. West J Med 1978; 128: 203–206.
- Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004; 38: 1651–1672.
- Tice AD. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the out-patient parenteral antimicrobial therapy outcomes registries. Chemotherapy 2001; 47 (Supp 1):5-16.
- Esposito S, Leone S, Noviello S, et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother 2007; 19: 392–397.
- Quintiliani R, Nightingale CH. Transitional antibiotic ther-apy. Infect Dis Clin Pract. 1994; 3 (Suppl):161-7.
- Siegel RE, Halpern NA, Almenoff PL, et al. A prospective randomized study of inpatient intravenous antibiotics for community-acquired pneumonia: the optimal duration of therapy. Chest 1996; 110: 965–71.
- Cunha BA. Intravenous to oral antibiotic switch therapy. Drugs Today 2001; 37: 311–319.
- Lode H, Grossman C, Choudhri S, et al. Sequential IV/P0 moxifloxacin treatment of patients with severe community-ac-quired pneumonia. Respir Med 2003; 97: 1134-42.
- Rebuck JA, Fish DN, Abraham E. Pharmacokinetics of in-travenous and oral levofloxacin in critically ill adults in a medical intensive care unit. Pharmacotherapy 2002; 22: 1216–25.
- P F, Furlanut M. Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients. J Chemother 2004; 16 (Suppl 2):8-10.
- McCue JD. Oral antibiotics practical prescribing rules for practitioners. Geriatrics 1992; 47: 59–66.
- Altemeier WA, Culbertson WR, Coith RL. The intestinal absorption of oral antibiotics in traumatic shock; an experimen-tal study. Surg Gynecol Obstet 1951; 92: 707–11.
- Power BM, Forbes AM, van Heerden PV, et al. Pharma-cokinetics of drugs used in critically ill adults. Clin Pharmacokinet 1998; 34: 25–56.
- Dunbar LM, Wunderink RG, Habib MP, et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003; 37: 752–60.
- File TM Jr, Milkovich G, Tennenberg AM, et al. Clinical implications of 750 mg 5-day levofloxacin for the treatment of community-acquired pneumonia. Curr Med Res Opin 2004; 20: 1473-1481.
- Cunha BA. Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumo-nia. Am J Med 2001; 111: 412–3.
- Cunha BA. Empiric oral monotherapy for hospitalized Patients with community-acquired pneumonia: an idea whose time has come. Eur J Clin Microbiol Infect Dis 2004; 23: 78–81.
- Cunha BA. Doxycycline for community-acquired pneu-monia. Clin Infect Dis 2003; 37: 870.
- Cunha BA: Doxycycline for nursing home acquired pneu-monia (NHAP). Scand J Infect Dis 2009; 41: 77–78.
- Cunha BA. Oral antibiotics to treat MRSA infections. J Hosp Infect 2005; 88–90.
- Ravidran V, John J, Kaye GC, et al. Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy. J Infect 2003; 47: 164–6.
- Kuwabara K, Shigeoka H, Ontonari T, et al. Successful treatment with minocycline of 2 cases of endocarditis caused by staphylococcus. Chemotherapy (Tokyo) 1985; 33: 904.
- Lawler MT, Sullivan MC, Levitz RE, et al. Treatment of prosthetic valve endocarditis due to methicillin-resistant Staphy-lococcus aureus with minocycline. J Infect Dis 1990; 161: 812–4.
- Ravidran V, John J, Kaye GC, et al. Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy. J Infect 2003; 47: 164–6.
- Hill EE, Herijgers P, Herregods M-C, et al. Infective en-docarditis treated with linezolid: case report and literature review. Eur J Clin Microbiol Infect Dis 2006; 25: 202–4.
- Waasbro, Hagberg L, et al. Intravenous ceftriaxone com-pared with oral doxycycline for the treatment of Lyme neu-roborreliosis. Scand J Infect Dis 2005; 37: 449–54.
- Cunha BA.Minocycline vs. doxycycline for the antimicro-bial therapy of Lyme neuroborreliosis. Clin Infect Dis 2000; 30: 237–238.
- Cunha BA. Oral vs IV treatment for catheter related blood-stream infections. Emerg Infect Dis 2007; 13: 1800–1801.
- Esposito S, Leone S, Noviello S, et al. Outpatient parenteral antibiotic therapy in the elderly: an Italian multicenter study. J Chemother 2009; 21 (2): 193–198.